Methods for tallying votes to determine a primary election's outcome include plurality counts and majority counts. Forty-one states require that a candidate receive a plurality of all votes cast in ...

and commercialize elafibranor for people living with Primary Biliary Cholangitis (PBC), and in other indications. Under the terms of the Ipsen agreement, GENFIT is eligible for regulatory ...

and commercialize elafibranor for people living with Primary Biliary Cholangitis (PBC), and in other indications. Under the terms of the Ipsen agreement, GENFIT is eligible for regulatory ...

The agreement grants Ipsen an exclusive worldwide license (excluding China, Hong Kong, Taiwan and Macau for which Terns Pharmaceuticals has a prior license) to develop, manufacture, and commercialize ...

The 2024 Universal Registration Document and Annual Financial Report (included in the Universal Registration Document), as well as the Annual Report on Form 20-F will be made public by the end of ...

was demonstrated in the accelerated approval of Iqirvo® (elafibranor 1) by the U.S. Food and Drug Administration, the European Medicines Agency and the Medicines and Healthcare Regulatory Agency ...

It offers customizable dashboards for better strategy planning and integrates various data sources for comprehensive analysis. Alpha Research provides in-depth analysis of stocks for investors and ...

Leap Therapeutics, Inc.'s DKN-01 showed disappointing results in the DisTinGuish trial for gastric and gastroesophageal junction cancer. The DeFianCe trial in colorectal cancer was closer to ...

In the study, PPAR agonist elafibranor was unable to hit the primary objective of resolving NASH without worsening fibrosis (scarring) compared to placebo, and also flunked its secondary targets.